glucocorticoid-dependent
Showing 1 - 25 of 4,504
Pericarditis Idiopathic Recurrent Trial in Athens (Hydroxychloroquine, Colchicine)
Not yet recruiting
- Pericarditis Idiopathic Recurrent
-
Athens, Attiki, Greece"Hippokration" General Hospital of Athens
Feb 20, 2023
Sarcoidosis Trial in Palo Alto (Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA]_#1, Placebos)
Active, not recruiting
- Sarcoidosis
- Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA]_#1
- Placebos
-
Palo Alto, CaliforniaStanford University
Jan 12, 2022
Chronic GVHD Trial in Hanzhou (TQ05105 Tablet)
Unknown status
- Chronic Graft Versus Host Disease
- TQ05105 Tablet
-
Hanzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University School of Med
Jun 26, 2021
Brain Metastases, Adult Trial in Edmonton (Glucocorticoid therapy)
Recruiting
- Brain Metastases, Adult
- Glucocorticoid therapy
-
Edmonton, Alberta, CanadaCross Cancer Institute
Mar 30, 2021
Safety and Efficacy Trial in Suzhou (Chidamide)
Recruiting
- Safety and Efficacy
-
Suzhou, Jiangsu, ChinaFirst Affiliated Hospital,Soochow University
Nov 30, 2021
Normal Physiology Trial run by the NIAID (Methylprednisolone sodium succinate(Solu-Medrol), Topical methylprednisolone (Advantan
Completed
- Normal Physiology
- Methylprednisolone sodium succinate(Solu-Medrol)
- Topical methylprednisolone (Advantan emulsion 0 /1%)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 18, 2022
Inflammatory Response, Pain, Postoperative, Nausea, Postoperative Trial in Aabenraa (Dexamethasone phosphate, Placebo)
Recruiting
- Inflammatory Response
- +4 more
- Dexamethasone phosphate
- Placebo
-
Aabenraa, DenmarkGyn. Dept.;Aabenraa Hospital, Sygehus Sønderjylland
Jul 11, 2022
Bronchial Inflammation, Small Airways Disfunction and Mucous
Not yet recruiting
- Asthma; Eosinophilic
- Dupilumab
- (no location specified)
Mar 15, 2023
ANCA-associated Vasculitis Trial in Brest (Blood samples (80 mL), Fecal samples, Urinary sample (20-40 mL))
Recruiting
- ANCA-associated Vasculitis
- Blood samples (80 mL)
- +3 more
-
Brest, FranceCHRU de Brest - Service de rhumatologie
Oct 28, 2022
Graves Ophthalmopathy Trial in Sofia (Methylprednisolone)
Completed
- Graves Ophthalmopathy
-
Sofia, BulgariaUniversity Hospital of Endocrinology
Mar 29, 2023
Systemic Lupus Erythematous (SLE) Trial run by the NIAMS (SOLU-MEDROL)
Recruiting
- Systemic Lupus Erythematous (SLE)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Severe Prednisone Dependent Eosinophilic Asthma Trial in Hamilton (Benralizumab, Placebo)
Recruiting
- Severe Prednisone Dependent Eosinophilic Asthma
- Benralizumab
- Placebo
-
Hamilton, Ontario, CanadaFirestone Institute for Respiratory Health, Research - St. Josep
Sep 6, 2021
High-dose Methylprednisolone in Fast-track Total Knee
Completed
- Infection of Total Knee Joint Prosthesis
-
Aarhus, Judland, Denmark
- +6 more
May 6, 2022
Urinary Artificial Sphincter in Children
Completed
- Neurogenic Bladder
- +3 more
- Urinary Artificial Sphincter (UAS) in Children
-
Vandœuvre-lès-Nancy, Grand-Est, FranceULorraine
May 14, 2023
Knee Osteoarthritis Trial (Sinomenine, Glucocorticoid)
Not yet recruiting
- Knee Osteoarthritis
- (no location specified)
Mar 1, 2023
Healthy Trial in Aarhus (Prednisolone)
Recruiting
- Healthy
-
Aarhus, State, DenmarkDepartment of Endocrinology and Internal Medicine
Sep 6, 2023
Cardiovascular Diseases Trial in Leiden (Mixed meal test)
Recruiting
- Cardiovascular Diseases
- Mixed meal test
-
Leiden, NetherlandsLeiden University Medical Center
Apr 12, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco
Recruiting
- Castration-Resistant Prostate Carcinoma
- +4 more
- Computed Tomography
- +3 more
-
San Francisco, CaliforniaUniversity of California San Francisco
Dec 19, 2022
Reduced-dose Alemtuzumab for Kidney Transplant Rejection
Not yet recruiting
- Kidney Transplant Rejection
- (no location specified)
Oct 25, 2023
Inflammatory Cardiomyopathy, Myocarditis Trial in Wuhan (Hydroxychloroquine, Prednisolone)
Recruiting
- Inflammatory Cardiomyopathy
- Myocarditis
-
Wuhan, Hubei, ChinaTongji Hospital
Jul 18, 2023
IgA Nephropathy Trial in Shanghai (rituximab group)
Active, not recruiting
- IgA Nephropathy
- rituximab group
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicin
Apr 9, 2023
IgG4-related Disease With Eosinophilia Trial in Beijing (Prednisolone, Baricitinib)
Recruiting
- IgG4-related Disease With Eosinophilia
-
Beijing, Bejing, ChinaPeking Union Medical College Hospital
Mar 23, 2023
Giant Cell Arteritis Trial (Secukinumab 300 mg, s.c., Placebo to match Secukinumab, s.c.)
Recruiting
- Giant Cell Arteritis
- Secukinumab 300 mg, s.c.
- Placebo to match Secukinumab, s.c.
-
Berlin, Germany
- +2 more
Oct 12, 2022
Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])
Not yet recruiting
- Immune Thrombocytopenia
- Treatment
- Obinutuzumab Injection [Gazyva]
-
Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital, Chinese Aca
Oct 17, 2023